Patanjali claims breakthrough in psoriasis cure, research published internationally

A new research conducted by Patanjali has been published in the internationally acclaimed Taylor & Francis journal, Inflammation Research, as per reports.

According to the publication, Patanjali has reportedly succeeded in developing an effective treatment for psoriasis using Psorogrit tablets and Divya Taila.

Acharya Balkrishna, the co-founder of Patanjali, reportedly stated that the organisation’s scientists have conducted extensive research and invented Psorogrit tablets and Divya Taila, which he described as ‘infallible medicines’ for psoriasis — a chronic autoimmune condition characterised by red, scaly patches on the skin and often accompanied by severe itching.

According to Balakrishna, psoriasis is a serious autoimmune disease that causes immense suffering, and until now, there was no known permanent cure. Today, Patanjali has demonstrated that even diseases deemed incurable can be treated through natural herbs, as per reports.

In the research, two Psorogrit tablets were reportedly administered to two different preclinical models — Imiquimod-induced and TPA-induced psoriasis in mice. Divya Taila was also applied topically to their skin. The results were reportedly positive, showing improvement in symptoms and inflammation.